Search Results - "FRIESLAND, S"

Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus or gastroesophageal junction: long-term results of a randomized clinical trial by von Döbeln, G A, Klevebro, F, Jacobsen, A-B, Johannessen, H-O, Nielsen, N H, Johnsen, G, Hatlevoll, I, Glenjen, N I, Friesland, S, Lundell, L, Yu, J, Nilsson, M

“…NeoRes I is a randomized phase II trial comparing neoadjuvant chemoradiotherapy with neoadjuvant chemotherapy in the treatment of resectable cancer of the…”
Get full text

A randomized clinical trial of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the oesophagus or gastro-oesophageal junction by Klevebro, F., Alexandersson von Döbeln, G., Wang, N., Johnsen, G., Jacobsen, A.-B., Friesland, S., Hatlevoll, I., Glenjen, N.I., Lind, P., Tsai, J.A., Lundell, L., Nilsson, M.

“…Neoadjuvant therapy improves long-term survival after oesophagectomy, treating oesophageal cancer, but the evidence to date is insufficient to determine which…”
Get full text

Health‐related quality of life in a randomized trial of neoadjuvant chemotherapy or chemoradiotherapy plus surgery in patients with oesophageal cancer (NeoRes trial) by Sunde, B., Klevebro, F., Johar, A., Johnsen, G., Jacobsen, A.‐B., Glenjen, N. I., Friesland, S., Lindblad, M., Ajengui, A., Lundell, L., Lagergren, P., Nilsson, M.

“…Background There are few data comparing health‐related quality of life (HRQoL) after neoadjuvant chemotherapy alone (nCT) compared with neoadjuvant…”
Get full text

Morbidity and mortality after surgery for cancer of the oesophagus and gastro-oesophageal junction: A randomized clinical trial of neoadjuvant chemotherapy vs. neoadjuvant chemoradiation by Klevebro, F, Johnsen, G, Johnson, E, Viste, A, Myrnäs, T, Szabo, E, Jacobsen, A.-B, Friesland, S, Tsai, J.A, Persson, S, Lindblad, M, Lundell, L, Nilsson, M

“…Abstract Objective To compare the incidence and severity of postoperative complications after oesophagectomy for carcinoma of the oesophagus and…”
Get full text

Brachytherapy and osteoradionecrosis in patients with base of tongue cancer by Danielsson, Daniel, Hagel, Eva, Dybeck-Udd, Sebastian, Sjöström, Mats, Kjeller, Göran, Bengtsson, Martin, Abtahi, Jahan, von Beckerath, Mathias, Thor, Andreas, Halle, Martin, Friesland, Signe, Mercke, Claes, Westermark, Anders, Högmo, Anders, Munck-Wikland, Eva

“…Base of tongue cancer incidence and patient survival is increasing why treatment sequelae becomes exceedingly important. Osteoradionecrosis (ORN) is a late…”
Get full text

Dose escalation to 84 Gy with concurrent chemotherapy in stage III NSCLC appears excessively toxic: Results from a prematurely terminated randomized phase II trial by Hallqvist, Andreas, Bergström, Stefan, Björkestrand, Hedvig, Svärd, Anna-Maja, Ekman, Simon, Lundin, Erik, Holmberg, Erik, Johansson, Mikael, Friesland, Signe, Nyman, Jan

“…•In this randomized trial escalated chemoradiotherapy in stage III NSCLC was too toxic.•The experimental group receiving 84 Gy had increased toxicity and…”
Get full text

PO-096: Cetuximab(CET), 5-FU and cisplatin or carboplatin (CA) vs CET, paclitaxel and CA in metastatic head and neck cancer by Friesland, S, Specht, L, Haugen, H, Söderström, K

Get full text

Effects of neoadjuvant chemoradiotherapy vs chemotherapy alone on the relief of dysphagia in esophageal cancer patients: secondary endpoint analysis in a randomized trial by Sunde, B, Johnsen, G, Jacobsen, A-B, Glenjen, N I, Friesland, S, Lindblad, M, Rouvelas, I, Wang, N, Lundell, L, Lagergren, P, Nilsson, M

“…Dysphagia is the most significant symptom in patients with esophageal cancer. There are different therapeutic interventions designed to relieve dysphagia, but…”
Get full text

Relief of dysphagia during neoadjuvant treatment for cancer of the esophagus or gastroesophageal junction by Sunde, B., Ericson, J., Kumagai, K., Lundell, L., Tsai, J. A., Lindblad, M., Rouvelas, I., Friesland, S., Wang, N., Nilsson, M.

“…Summary Dysphagia is the main symptom of cancer of the esophagus and gastroesophageal junction and causing nutritional problems and weight loss, often…”
Get full text

Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer – A first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study by Baumann, Pia, Nyman, Jan, Hoyer, Morten, Gagliardi, Giovanna, Lax, Ingmar, Wennberg, Berit, Drugge, Ninni, Ekberg, Lars, Friesland, Signe, Johansson, Karl-Axel, Lund, Jo-Åsmund, Morhed, Elisabeth, Nilsson, Kristina, Levin, Nina, Paludan, Merete, Sederholm, Christer, Traberg, Anders, Wittgren, Lena, Lewensohn, Rolf

“…Abstract Background and Aims In a retrospective study using stereotactic body radiotherapy (SBRT) in medically inoperable patients with stage I NSCLC we…”
Get full text

Combined stent insertion and single high-dose brachytherapy in patients with advanced esophageal cancer - results of a prospective safety study by Bergquist, H., Johnsson, E., Nyman, J., Rylander, H., Hammerlid, E., Friesland, S., Ejnell, H., Lundell, L., Ruth, M.

“…SUMMARY Previous randomized studies comparing the two commonly used palliative treatments for incurable esophageal cancer, i.e. stent insertion and…”
Get full text

The management and survival outcomes of nasopharyngeal cancer in the Nordic countries by Mäkitie, A, Ruuskanen, M, Bentzen, J, Brun, E, Gebre-Medhin, M, Friesland, S, Marsk, E, Hammarstedt-Nordenvall, L, Gille, E, Reizenstein, J, Adell, G, Farnebo, L, Rzepecki, J, Haugen, H, Söderström, K, Zackrisson, B, Bergström, S, Lödén, B, Cederblad, L, Laurell, G, Smeland, E, Folkvard Evensen, J, Lund, J Å, Tøndel, H, Karlsdottir, Å, Jóhannsson, J, Johansen, J, Kristensen, C A, Jensen, K, Andersen, L J, Koivunen, P, Korpela, M, Voutilainen, L, Wigren, T, Minn, H, Joensuu, H, Overgaard, J, Saarilahti, K

Get more information

OC-0565: SPACE - A randomized study of SBRT vs conventional fractionated radiotherapy in medically inoperable stage I NSCLC by Nyman, J, Hallqvist, A, Lund, J.A, Brustugun, O.T, Bergström, P, Friesland, S, Lewensohn, R, Drugge, N, Rylander, H, Lax, I

Get full text

SP-035: Five-Year Results of the ARTSCAN Randomised Trial on Accelerated Radiotherapy by Zackrisson, B, Nilsson, P, Kjellén, E, Johansson, K.A, Söderström, K, Brun, E, Nyman, J, Friesland, S, Reizenstein, J, Sjödin, H

Get full text

How to improve loco-regional control in stages IIIa―b NSCLC? Results of a three-armed randomized trial from the Swedish Lung Cancer Study Group by NYMAN, J, FRIESLAND, S, HALLQVIST, A, SEKE, M, BERGSTRÖM, S, THANING, L, LÖDEN, B, SEDERHOLM, C, WAGENIUS, G

“…A combination of chemotherapy and radiotherapy is the treatment base for locally advanced non-small cell lung cancer (NSCLC). However, both loco-regional and…”
Get full text

Phase II studies on docetaxel alone every third week, or weekly in combination with gemcitabine in patients with primary locally advanced, metastatic, or recurrent esophageal cancer by Albertsson, M, Johansson, B, Friesland, S, Kadar, L, Letocha, H, Frykholm, G, Wagenius, G

“…The purpose of these studies was to compare efficacy and toxicity of docetaxel alone with the combination of gemcitabine and docetaxel for treatment of…”
Get full text

How to improve loco-regional control in stages IIIa–b NSCLC? by Nyman, J, Friesland, S, Hallqvist, A, Seke, M, Bergström, S, Thaning, L, Lödén, B, Sederholm, C, Wagenius, G

“…Abstract Background A combination of chemotherapy and radiotherapy is the treatment base for locally advanced non-small cell lung cancer (NSCLC). However, both…”
Get full text

Anemia and quality of life including anemia-related symptoms in patients with solid tumors in clinical practice by Bremberg, E Rämme, Brandberg, Y, Hising, C, Friesland, S, Eksborg, S

“…The aim of this study was to explore in a clinical setting the association between hemoglobin (Hb) level and quality of life (QoL) including anemia-related…”
Get full text

PO-1240 Large primary tumours of oropharyngeal cancer may benefit from radiation dose escalation by Embring, A., Onjukka, E., Mercke, C., Lax, I., Berglund, A., Friesland, S.

Get full text

Effect of corticosteroids on the outcome of patients with advanced non–small cell lung cancer treated with immune-checkpoint inhibitors by Skribek, Marcus, Rounis, Konstantinos, Afshar, Soren, Grundberg, Oscar, Friesland, Signe, Tsakonas, Georgios, Ekman, Simon, De Petris, Luigi

“…We analysed patients with advanced non–small cell lung cancer (NSCLC) who were treated with immune-checkpoint inhibitors (ICIs) to address the effect of the…”
Get full text